Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Prognostic implications of ΔNp73/TAp73 expression ratio in core-binding factor acute myeloid leukemia

    Maria L. Salustiano-Bandeira, Amanda Moreira-Aguiar in Blood Cancer Journal (2024)

  2. Article

    Open Access

    Inhibition of the succinyl dehydrogenase complex in acute myeloid leukemia leads to a lactate-fuelled respiratory metabolic vulnerability

    Metabolic programs can differ substantially across genetically distinct subtypes of acute myeloid leukemia (AML). These programs are not static entities but can change swiftly as a consequence of extracellular...

    Ayşegül Erdem, Silvia Marin, Diego A. Pereira-Martins in Nature Communications (2022)

  3. Article

    Open Access

    The Glycolytic Gatekeeper PDK1 defines different metabolic states between genetically distinct subtypes of human acute myeloid leukemia

    Acute myeloid leukemia remains difficult to treat due to strong genetic heterogeneity between and within individual patients. Here, we show that Pyruvate dehydrogenase kinase 1 (PDK1) acts as a targetable dete...

    Ayşegül Erdem, Silvia Marin, Diego A. Pereira-Martins in Nature Communications (2022)

  4. Article

    Open Access

    MLL5 improves ATRA driven differentiation and promotes xenotransplant engraftment in acute promyelocytic leukemia model

    Although the mixed lineage leukemia 5 (MLL5) gene has prognostic implications in acute promyelocyte leukemia (APL), the underlying mechanism remains to be elucidated. Here, we demonstrate the critical role exerte...

    Diego A. Pereira-Martins, Isabel Weinhäuser, Juan Luiz Coelho-Silva in Cell Death & Disease (2021)

  5. Article

    Open Access

    Molecular-Based Score inspired on metabolic signature improves prognostic stratification for myelodysplastic syndrome

    Deregulated cellular energetics is formally incorporated as an emerging hallmark of cancer, however little is known about its processes in myelodysplastic syndromes (MDS). Using transcriptomic data of CD34+ ce...

    Juan L. Coelho-Silva, Douglas R. A. Silveira in Scientific Reports (2021)

  6. Article

    Open Access

    NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia

    Non-T cell activation linker (NTAL) is a lipid raft-membrane protein expressed by normal and leukemic cells and involved in cell signaling. In acute promyelocytic leukemia (APL), NTAL depletion from lipid raft...

    Carolina Hassibe Thomé, Germano Aguiar Ferreira in Scientific Reports (2020)

  7. Article

    Open Access

    Targeting the mitochondria in acute myeloid leukemia

    Acute myeloid leukemia (AML) is a clonal hematologic neoplasm characterized by heterogeneity of genetic abnormalities found at diagnosis. These abnormalities serve to classify patients by risk group into low, ...

    Silvia Elena Sánchez-Mendoza, Eduardo M. Rego in Applied Cancer Research (2017)

  8. No Access

    Reference Work Entry In depth

    Acute Promyelocytic Leukemia

    Li-Zhen He, Lorena L. Figueiredo-Pontes, Eduardo M. Rego in Encyclopedia of Cancer (2017)

  9. No Access

    Article

    All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies

    Front-line treatment of acute promyelocytic leukaemia (APL) consists of all-trans retinoic acid (ATRA) and anthracycline-based chemotherapy. In this setting, a comparison of idarubicin and daunorubicin has never ...

    Miguel A. Sanz, Pau Montesinos, Haesook T. Kim in Annals of Hematology (2015)

  10. Article

    Open Access

    Halofuginone inhibits phosphorylation of SMAD-2 reducing angiogenesis and leukemia burden in an acute promyelocytic leukemia mouse model

    Halofuginone (HF) is a low-molecular-weight alkaloid that has been demonstrated to interfere with Metalloproteinase-2 (MMP-2) and Tumor Growth Factor-β (TGF-β) function and, to present antiangiogenic, antiprol...

    Patricia A. Assis in Journal of Experimental & Clinical Cancer … (2015)

  11. No Access

    Article

    Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer

    All-trans retinoic acid binds to, inhibits and induces degradation of the active form of the prolyl isomerase Pin1, thereby turning off and on a variety of Pin1 substrate oncogenes and tumor suppressors, respecti...

    Shuo Wei, Shingo Kozono, Lev Kats, Morris Nechama, Wenzong Li in Nature Medicine (2015)

  12. No Access

    Living Reference Work Entry In depth

    Acute Promyelocytic Leukemia

    Li-Zhen He, Lorena L. Figueiredo-Pontes, Eduardo M. Rego in Encyclopedia of Cancer

  13. No Access

    Article

    Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia study

    Activating internal tandem duplication (ITD) mutations in the fms-like tyrosine kinase 3 (FLT3) gene (FLT3-ITD) are associated with poor outcome in acute myeloid leukemia, but their prognostic impact in acute pro...

    Antonio R. Lucena-Araujo, Haesook T. Kim, Rafael H. Jacomo in Annals of Hematology (2014)

  14. Article

    Open Access

    Increased expression of miR-221 is associated with shorter overall survival in T-cell acute lymphoid leukemia

    CD56 expression has been associated with a poor prognosis in lymphoid neoplasms, including T-cell acute lymphoblastic leukemia (T-ALL). MicroRNAs (miRNAs) play an important role in lymphoid differentiation, an...

    Hamilton L Gimenes-Teixeira, Antonio R Lucena-Araujo in Experimental Hematology & Oncology (2013)

  15. No Access

    Article

    Acute promyelocytic leukemia associated with the PLZF-RARA fusion gene: two additional cases with clinical and laboratorial peculiar presentations

    Acute promyelocytic leukemia (APL) is characterized by the presence of the t(15;17) and PML-RARa rearrangement, with good response to treatment with retinoids. However, few cases of variant APL involving alter...

    Sandra S. Rohr, Luís Arthur Flores Pelloso, Aline Borgo in Medical Oncology (2012)

  16. No Access

    Article

    Cardiac stunning as a manifestation of ATRA differentiation syndrome in acute promyelocytic leukemia

    Gil C. De Santis, Maria Isabel A. Madeira, Luciana C. O. de Oliveira in Medical Oncology (2012)

  17. No Access

    Reference Work Entry In depth

    Acute Promyelocytic Leukemia

    Li-Zhen He, Pier Paolo Pandolfi, Eduardo M. Rego in Encyclopedia of Cancer (2011)

  18. Article

    Erratum to: Results of FLT3 mutation screening and correlations with immunophenoty** in 169 Brazilian patients with acute myeloid leukemia

    Antonio R. Lucena-Araujo, Danielle L. Souza in Annals of Hematology (2010)

  19. No Access

    Article

    Results of FLT3 mutation screening and correlations with immunophenoty** in 169 Brazilian patients with acute myeloid leukemia

    Antonio R. Lucena-Araujo, Danielle L. Souza in Annals of Hematology (2010)

  20. No Access

    Reference Work Entry In depth

    Acute Promyelocytic Leukemia

    Li-Zhen He, Lorena L. Figueiredo-Pontes, Eduardo M. Rego in Encyclopedia of Cancer (2009)

previous disabled Page of 2